Introduction
Platelets have been shown to affect the metabolism and the function of vascular endothelium (1) (2) (3) (4) (5) . Apart from these wellrecognized interactions between platelets and endothelial cells, in areas such as thrombosis, hemostasis, and vascular permeability, some studies have suggested that factors from the platelets may also contribute to the preservation of capillary integrity (6) (7) (8) (9) . Gimbrone et al. showed that thyroid glands perfused with Receivedfor publication 7 July 1983 and in revisedform 23 September 1983. plasma lacking in platelets exhibited more breakdown ofcapillary endothelium than the same organ exposed to plasma supplemented with platelets (6) . Earlier clinical observations noted a close association between thrombocytopenia and purpuric hemorrhages (9-1 1).
Growth factors have been clearly demonstrated in platelets. One of the best characterized is platelet-derived growth factor (PDGF),1 which can stimulate the growth of vascular smooth muscle cells and fibroblasts (12) (13) (14) . However, PDGF has not been found to be biologically active in endothelial cells (14, 15) . Several groups have demonstrated that whole platelets can actually stimulate the growth of endothelial cells (6) (7) (8) (9) , although others could not replicate this finding in platelet lysates (16, 17) . In the present report, we have partially purified and characterized an endothelial growth factor (ENDO-GF) from human platelets that appear to be capable ofstimulating DNA synthesis and cell growth in cultured human endothelial cells.
Methods
Purification procedures. Outdated human platelets were purchased from New England Blood Service (Boston, MA). The platelets were washed in phosphate-buffered saline (PBS) without Ca"+ and Mg"+ and centrifuged at 20,000 g. All purification steps were carried out at 40C. The platelets were suspended in PBS at a concentration of 50 mg/ml of protein and lysed by ultrasonication for 1 min (sonifier cell distruptor 200; Branson Sonic Power Co., Danbury, CT). After sonication, the platelet lysate was ultracentrifuged (Beckman Instruments Inc., Fullerton, CA) at 100,000 g for 60 min and precipitate was discarded. The supernatant was dialyzed against PBS for 24 h using dialysis membrane (Fisher Scientific Co., Chicago, IL) with molecular weight exclusion of 10,000-14,000, then fractionated through a Sephacryl S-200 column (1.5 X 80 cm, Pharmacia Fine Chemicals Inc., Piscataway, NJ).
Culture ofhuman endothelial cells. Primary human endothelial cells from umbilical veins were generously provided by Dr. M. Gimbrone, Jr. (Brigham and Women's Hospital), were serially passaged by the method of Maciag et al. using partially purified ENDO-GF from bovine hypothalamus, and grown on fibronectin-treated tissue culture dishes (18, 19) . Umbilical cells were used up to 10 passages. The endothelial cells retained their morphological features as observed by inverted phase contrast microscopy. In addition, the cells were found to be positive for Factor VIII antigen using indirect immunofluorescence with antibody to human Factor VIII (20, 21) .
[3H]Thymidine incorporation into DNA. Cells were grown to near confluence at 370C in six well plates (Costar, Cambridge, MA). The growth media of M199, containing 10% fetal bovine serum (FBS) and ENDO-GF from bovine hypothalamus, was replaced with M199 media containing 0.5% FBS and 2.5 mg/ml of bovine serum albumin at pH 7.4 for 24 h. Indicated concentrations of growth factors or ENDO-GF were added for 14-18 h before the cells were pulsed with [3H]thymidine, 2 ACi/ml, for 30 min at 370C. The cells were solubilized with 0.1% sodium dodecyl sulfate and the DNA precipitated with 10% trichloroacetic acid at 4VC as described previously (21) (22) (23) .
Cell number determination. Cell number was determined using a hemocytometer and Coulter counter (Coulter Electronics Inc., Hialeah, FL). The cells were released from the dishes by trypsin-EDTA and diluted sufficiently to prevent significant aggregation. The cell preparations were then counted in triplicate.
Protein assays. Protein concentration was estimated by the method of Lowry et al. with bovine serum albumin as standard (24) . Pure PDGF was a generous gift of Dr. C.-H. Heldin (University of Uppsala, Sweden).
Plasma-derived fetal bovine serum and FBS were purchased from Sterile Systems Inc. (Logan, UT).
Results
Partialpurification ofENDO-GFfrom human platelets. Outdated human platelets were lysed by sonication. The crude lysate was ultracentrifuged at 100,000 g. The supernatant was then dialyzed 25,000 z 0 I-i- 5 2,000-using membrane with molecular weight exclusion of 10,000-14,000. Preparations from the various steps in the purification of ENDO-GF (see Methods) were assayed for their potency to stimulate [3H]thymidine incorporation into DNA of human umbilical vein endothelial cells as shown in Fig. 1 (top) . Whole platelets and platelet lysate stimulated DNA synthesis equally well in a dose-dependent manner. The growth-promoting activity appears to be due to a large and soluble molecule, since it was found in the supernatant fraction after ultracentrifugation and was not dialyzable. Further purification was achieved using gel chromatography with Sephacryl S-200. Fractions eluted off the Sephacryl S-200 column were assayed for growth-promoting effects on both human fibroblasts and endothelial cells (Fig. 1,  bottom) . Three peaks of activity for growth effects in human endothelial cells were found corresponding with approximate molecular weight of 135,000, 65,000, and total volume of the column. When assayed in human fibroblasts, three different peaks of growth-promoting effects were observed in the areas of void volume, molecular weight of 40,000, and the total volume. The peak at the approximate molecular weight of 40,000 was probably due to PDGF, which has a reported molecular weight of 30,000-36,000 (13, 14 (Fig. 2) .
Effect ofENDO-GF on the growth ofendothelial cells. Besides being able to stimulate DNA synthesis, ENDO-GF was also able to increase cell numbers, as shown in Fig. 3 . FBS alone could increase endothelial cell growth by 30%. However, the addition of either partially purified ENDO-GF or crude platelet lysate with 10% FBS stimulated cell growth by >100% above the FBS alone. The growth effects of ENDO-GF, alone and combined with various growth media, were studied. As shown in Table I , the purified crude platelet lysate could stimulate DNA synthesis and a cell number increase, whereas the Sephacryl columnpurified ENDO-GF stimulated only DNA synthesis. However, when ENDO-GF was added with either FBS or plasma-derived FBS, both DNA synthesis and cellular proliferation were stimulated by two to threefolds greater than serum or plasma alone.
Note that, although plasma and serum stimulated [3H]thymidine incorporation after 16 h ofpreincubation to a lesser degree than ENDO-GF or platelet lysate, they were equally potent in increasing cellular proliferation.
Characterization of ENDO-GF. When ENDO-GF was incubated at various temperatures, its biological potency was diminished by >50% at 370C and lost almost all its effects when incubated at 570 and 1000C for 30 min (Fig. 4) .
In addition to being heat labile, ENDO-GF was also sensitive Figure 2 . A comparison of the specificity of the growth effect of ENDO-GF and PDGF on human umbilical vein endothelial cells (left) and human fibroblasts (right). Partially purified ENDO-GF after the gel chromatography step and pure PDGF were used for these experiments. Procedures for the [3H]thymidine incorporation assay have been described previously (21) (22) (23) .
to the proteolytic action of trypsin. ENDO-GF was progressively inactivated by treatment with increasing concentrations oftrypsin between 0.1 and 1%. However, when trypsin inhibitor was added simultaneously with the trypsin, no inhibition of the growth-promoting action was observed. Similarly, no inhibition was observed if trypsin and ENDO-GF were incubated at 4VC.
These data strongly suggest that ENDO-GF from human platelets is a heat-labile protein or proteins.
Discussion
Platelets contain many bioactive agents that affect the metab- proximate molecular weights of 65,000 and 135,000. These two peaks could be in the form of monomer and dimer or could represent two different proteins. A third peak of activity, which was eluted from the column at the region of total volume, was probably due to the small molecules that have been shown recently to affect the growth of endothelial cells (9) . Biochemical characterization using trypsin and heat demonstrated that ENDO-GF is a protein and very heat labile. This extreme heat lability is probably the reason that other investigators were unable to demonstrate an effect on endothelial cells using platelet lysates. Because ENDO-GF was ineffective in human fibroblasts, it appears to be biologically specific for endothelial cells, although other cells have to be screened.
It is interesting that the ENDO-GF could increase the growthpromoting effect of both plasma and serum, since serum should contain all the factors released from the platelets which are the source ofENDO-GF. The most likely explanation is that ENDO-GF in the serum has been denatured due to its extreme lability, exhibited by its loss of biological activity when tested above 370C. Alternatively, the growth factor activity could have been lost from the serum during the clotting process, indicating a relationship between this growth factor and the clotting mechanism.
The biochemical and biological properties of ENDO-GF are very different from those of PDGF. PDGF is a much smaller protein at 30,000 mol wt. PDGF is not inactivated at 560 or 100IC and biologically has the reverse spectrum of ENDO-GF, since it is very potent in fibroblasts and has no effect on endothelial cells. ENDO-GF activity, in contrast, is associated with larger 65,000 and 135,000 heat-labile proteins that can stimulate endothelial cell growth. The large molecular size of ENDO-GF is rather unusual among other endothelial growth factors (25-29). Maciag et al. have purified an ENDO-GF from bovine hypothalamus which is approximated to have molecular weights of 25,000 and 70,000; however, it is possible that ENDO-GF, like the insulin-like growth factors, is associated with a l0,00oo binding protein that is responsible for the high molecular weight estimation (30, 31). The demonstration of an ENDO-GF from human platelets suggests that platelets may have a growth-promoting role in vascular endothelial cells, perhaps at the process of endothelial cell regeneration, which is a crucial step in the healing of endothelial cell injury. Further work is in progress for the complete purification and characterization of ENDO-GF from human platelets.
